The mechanism of <italic>Xiaoban Yushen Formula</italic> (消斑愈肾方) in alleviating purpuric nephritis injury via regulating system Xc-/GPx4/ACSL4/LPCAT3

<sec> <title>目的</title> 探究消斑愈肾方对紫癜性肾炎模型大鼠SLC7A11/P53/ACSL4/LPCAT3/GPx4表达的影响及相关调控机制。 </sec> <sec> <title>方法</title> SPF级SD大鼠80只,随机分成正常组、模型组、西药组、中药低剂量组、中药中剂量组和中药高剂量组6组。除正常组外,每组均采用OVA卵蛋白腹腔注射联合皮内注射激发法建立模型。通过观察大鼠皮肤紫癜形成情况判断模型成功与否。造模成功后,每组灌胃剂量为1mL/100g,日1次。连续灌胃21d后取材,DHE法观察肾组织ROS含量,WB、qRT-PCR法检测上述指标表达情况。 </sec> <sec> <title>结果</title> 与正常组比较,模型组大鼠肾组织ROS含量显著增多,肾单位破坏明显,内皮细胞肿胀,细胞外基质增厚,p53/ACSL4/LPCAT3表达显著升高;SLC7A11表达明显降低(<italic>P</italic>&lt;0.01)。与模型组比较,中药各组及西药组病理改变明显减轻,ROS含量减少,P53/ACSL4/LPCAT3表达较低;SLC7A11/GPx4表达升高<italic>(P&lt;</italic>0.01)。西药组和中药中剂量组病理改变相近,相关指标水平中药中剂量组要优于西药组<italic>(P&lt;</italic>0.05)。 </sec> <sec> <title>结论</title> 消斑愈肾方可以抑制模型大鼠肾中ACSL4/LPCAT3表达,减轻细胞内脂质的过氧化;提升SLC7A11/GPx4的表达,抑制p53的表达,调节GSH/GSSG水平,减少ROS的过度积累,减轻脂质过氧化。其可能的机制为:消斑愈肾方通过调节细胞内活性氧水平,减少脂质过氧化,抑制铁死亡进程,减轻肾脏受累,改善肾功能。 </sec>

Authors

Publication Details

Journal
Lishizhen medicine and materia medica research
Published
2025-12-01
DOI
https://doi.org/10.70976/j.1008-0805.szgygy-2025-2307
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The mechanism of &lt;italic&gt;Xiaoban Yushen Formula&lt;/italic&gt; (消斑愈肾方) in alleviating purpuric nephritis injury via regulating system Xc-/GPx4/ACSL4/LPCAT3

Zhihui Liu, Xue Gong, Xiaohong Bai, Xiaoyu LU et al.
Lishizhen medicine and materia medica research
Gout, Hyperuricemia, Uric Acid
article

The mechanism of &lt;italic&gt;Xiaoban Yushen Formula&lt;/italic&gt; (消斑愈肾方) in alleviating purpuric nephritis injury via regulating system Xc-/GPx4/ACSL4/LPCAT3

Zhihui Liu, Xue Gong, Xiaohong Bai, Xiaoyu LU, Shengzhi WANG, Shaoqing Zhang, Chan XIU, Dexue MENG, Fan Zhang, Jun Zhang, Shuhui YANG
article en

Abstract

<sec> <title>目的</title> 探究消斑愈肾方对紫癜性肾炎模型大鼠SLC7A11/P53/ACSL4/LPCAT3/GPx4表达的影响及相关调控机制。 </sec> <sec> <title>方法</title> SPF级SD大鼠80只,随机分成正常组、模型组、西药组、中药低剂量组、中药中剂量组和中药高剂量组6组。除正常组外,每组均采用OVA卵蛋白腹腔注射联合皮内注射激发法建立模型。通过观察大鼠皮肤紫癜形成情况判断模型成功与否。造模成功后,每组灌胃剂量为1mL/100g,日1次。连续灌胃21d后取材,DHE法观察肾组织ROS含量,WB、qRT-PCR法检测上述指标表达情况。 </sec> <sec> <title>结果</title> 与正常组比较,模型组大鼠肾组织ROS含量显著增多,肾单位破坏明显,内皮细胞肿胀,细胞外基质增厚,p53/ACSL4/LPCAT3表达显著升高;SLC7A11表达明显降低(<italic>P</italic>&lt;0.01)。与模型组比较,中药各组及西药组病理改变明显减轻,ROS含量减少,P53/ACSL4/LPCAT3表达较低;SLC7A11/GPx4表达升高<italic>(P&lt;</italic>0.01)。西药组和中药中剂量组病理改变相近,相关指标水平中药中剂量组要优于西药组<italic>(P&lt;</italic>0.05)。 </sec> <sec> <title>结论</title> 消斑愈肾方可以抑制模型大鼠肾中ACSL4/LPCAT3表达,减轻细胞内脂质的过氧化;提升SLC7A11/GPx4的表达,抑制p53的表达,调节GSH/GSSG水平,减少ROS的过度积累,减轻脂质过氧化。其可能的机制为:消斑愈肾方通过调节细胞内活性氧水平,减少脂质过氧化,抑制铁死亡进程,减轻肾脏受累,改善肾功能。 </sec>

Lishizhen medicine and materia medica researchVol. 36(23)
Good health and well-being
Openalex Percentile: Top 27%
Gout, Hyperuricemia, Uric Acid
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.